MT-1
MODERATE EVIDENCEAlso known as: Melanotan 1, Afamelanotide analogue
Analogue of a compound approved in limited territories — research supply is not a medicine
Educational Overview
An alpha-MSH analogue studied for effects on melanogenesis. A related molecule holds narrow regulatory approval in some jurisdictions for a rare photosensitivity condition.
Research Mechanism
Acts on melanocortin-1 receptors involved in pigmentation signalling.
Areas of Study
- Melanogenesis research
- Photoprotection (clinical, narrow indication)
Safety Considerations
Research-supplied material is not an approved medicine. Unapproved melanocortin analogues have been associated in case reports with changes to pigmented lesions; dermatological monitoring concerns are documented. Research material only.
Frequently Asked Questions
Is this approved for human use?
No. This material is supplied for laboratory research use only by qualified businesses and institutions. It is not a medicine and is not for human or veterinary consumption.
How do I get pricing?
Request a quote and our team will respond with current pricing and available sizes for your account.
Do you provide purity documentation?
Certificates of analysis are available to approved accounts. Contact our team for batch-specific documentation.
References
References pending editorial review
We publish citations only after a qualified reviewer has verified them against the primary literature. We do not list references we have not checked. (1 queued.)
Last reviewed: 2026-07-23 · Status: in_review · References verified by editorial review before publication.
Disclaimer: Educational only. Not medical advice, diagnosis, or treatment. For research and educational purposes. Consult a licensed medical professional.
